However, in a survival analysis of the responders (Supplementary Figure S1A), the G-CSF-positive cervical cancer patients exhibited shorter PFS and OS than the G-CSF-negative cervical cancer patients (median PFS: 8.5 months vs. 20 months, p = 0.0687; median OS: 24.5 months vs. 62 months, p = 0.0341), indicating that the responses of the G-CSF-positive cervical cancer patients did not last as long as those of the G-CSF-negative cervical cancer patients. Here, CSF3 is linked to cervical cancer.